| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/06/2013 | CN102949615A Medicine for treating hypertension |
| 03/06/2013 | CN102949602A Health-care product tablet for treating hypertension and preparation method thereof |
| 03/06/2013 | CN102949600A Preparation method of folium llicis latifoliae hypotensive capsule |
| 03/06/2013 | CN102949599A Traditional Chinese preparation for reducing blood pressure |
| 03/06/2013 | CN102949570A Traditional Chinese medicine for treating neurasthenia |
| 03/06/2013 | CN102949535A Chinese herbal preparation resistant to hyperlipidemia and atherosclerosis and preparation method of Chinese herbal preparation |
| 03/06/2013 | CN102949532A Health care product capsule used for replenishing qi and enriching blood and preparation method thereof |
| 03/06/2013 | CN102949517A Chinese wolfberry root-bark pure powder buccal tablets and preparation method thereof |
| 03/06/2013 | CN102949493A Health care product capsule for treating coronary disease and preparation method thereof |
| 03/06/2013 | CN102949488A Traditional Chinese medicine used for preventing and treating hypertension |
| 03/06/2013 | CN102949481A Health care tea for reducing blood pressure and blood lipid |
| 03/06/2013 | CN102949479A Dispersible tablet of traditional Chinese medicine used for preventing heart diseases and preparation method thereof |
| 03/06/2013 | CN102949466A Foot bathing liquid for yang promotion and solid doff |
| 03/06/2013 | CN102949446A Application of cinnamon oil for preparing medicine for treating arrhythmia and medicine prepared by cinnamon oil |
| 03/06/2013 | CN102949445A Pure traditional Chinese medicine preparation for activating blood circulation to dissipate stasis and preparation method thereof |
| 03/06/2013 | CN102949440A Licoflavone phospholipid complex and preparation method and application thereof |
| 03/06/2013 | CN102949437A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 03/06/2013 | CN102949420A Preparation method of medicinal flavonoid by ginkgo leaf extraction |
| 03/06/2013 | CN102949419A Lucid ganoderma drying method |
| 03/06/2013 | CN102949403A Celecoxib composition, and preparation method and application thereof |
| 03/06/2013 | CN102949402A Celecoxib composition, and preparation method and use thereof |
| 03/06/2013 | CN102949398A Hypotensive compound preparation and preparation method thereof |
| 03/06/2013 | CN102949395A Application of vardenafil hydrochloride tables in preparation of medicine for treating pulmonary arterial hypertension |
| 03/06/2013 | CN102949391A Medicinal composition acting on heart and blood vessels |
| 03/06/2013 | CN102949377A Acetazolamide sustained-release capsule and preparation method thereof |
| 03/06/2013 | CN102949375A Berberine hydrochloride solid lipid nano preparation and preparation method thereof |
| 03/06/2013 | CN102949363A Ursolic acid liquid-solid compression tablet |
| 03/06/2013 | CN102949362A Orally-taken solid medicinal composition containing trandolapril and preparation method thereof |
| 03/06/2013 | CN102949360A Solid pharmaceutical composition for buccal administration of agomelatine |
| 03/06/2013 | CN102949355A Medicinal composite freeze-dried agent for treating acute heart failure and preparation method thereof |
| 03/06/2013 | CN102948903A Health-care beverage |
| 03/06/2013 | CN102948758A Method for extracting buckwheat flavone from buckwheat bran |
| 03/06/2013 | CN102948556A Raw flos sophorae blood pressure-reducing tea |
| 03/06/2013 | CN102948504A Sobering-up and alcoholism relieving tea and its use |
| 03/06/2013 | CN102614120B Preparation method for sinomenine hydrochloride eye drops |
| 03/06/2013 | CN102552155B Lidocaine nanometer calcium phosphate preparation and preparation method thereof |
| 03/06/2013 | CN102525910B Process for preparing penehyclidine hydrochloride injection |
| 03/06/2013 | CN102491940B Nisoldipine compound and novel preparation method thereof |
| 03/06/2013 | CN102327263B Compound medicinal composition for reducing blood pressure, and compound tablet for reducing blood pressure |
| 03/06/2013 | CN102309544B Preparation method of capsule for treating cardiovascular diseases |
| 03/06/2013 | CN102218058B Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy |
| 03/06/2013 | CN102205113B Novel application of Jingzhaotoxin |
| 03/06/2013 | CN102178718B Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease |
| 03/06/2013 | CN101926922B Chinese patent medicament for treating cerebrovascular diseases and preparation method thereof |
| 03/06/2013 | CN101843892B Medicament composition comprising Enalapril quick-releasing part and felodipine slow-releasing part |
| 03/06/2013 | CN101785581B Smoking-cessation and health-care cigarette holders and using method thereof |
| 03/06/2013 | CN101679273B 1-substituted tetrahydroisoquinoline compound |
| 03/06/2013 | CN101443004B Formulations and methods for vascular permeability-related diseases or conditions |
| 03/06/2013 | CN101010101B Composition comprising protein material and non-oxidizable fatty acid entities |
| 03/05/2013 | US8389747 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 03/05/2013 | US8389511 Bicyclic heterocyclic derivative |
| 03/05/2013 | US8389500 Fused heterocyclic compounds as ion channel modulators |
| 03/05/2013 | US8389279 α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8388989 Articles of clothing treated with ammonia oxidizing bacteria to produce nitric oxide |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 02/28/2013 | WO2013028968A1 3-dimensional cardiac fibroblast derived extracellular matrix |
| 02/28/2013 | WO2013028140A1 Tribulus terrestris, avena sativa and panax ginseng extract combination |
| 02/28/2013 | WO2013027188A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/28/2013 | WO2013026878A1 Anti-vcam-1 nanobodies |
| 02/28/2013 | WO2013026852A2 Derivatives of mecamylamine |
| 02/28/2013 | WO2013026270A1 Use of dexibuprofen levocetirizine double-layer sustained release tablet in treatment of airway inflammation |
| 02/28/2013 | WO2013026264A1 Cb1 acceptor inhibitor compound with nitrogen-containing aromatic ring having hydroxyl and use thereof |
| 02/28/2013 | WO2012175745A9 Cell secreted proteins for the treatment of myocardial infarction |
| 02/28/2013 | WO2012141615A3 Medicament |
| 02/28/2013 | US20130053441 Novel ester derivative and use thereof |
| 02/28/2013 | US20130053438 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053430 Modulation of cetp expression |
| 02/28/2013 | US20130053417 Cetp activity inhibitors |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053414 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 02/28/2013 | US20130053413 Crystalline forms of pitavastatin calcium |
| 02/28/2013 | US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 02/28/2013 | US20130053411 Pharmaceutical composition and method for treating hypertension |
| 02/28/2013 | US20130053408 Methods and compositions utilizing quinazolinones |
| 02/28/2013 | US20130053404 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/28/2013 | US20130053402 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053401 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof |
| 02/28/2013 | US20130053379 4-aryl-2-anilino-pyrimidines |
| 02/28/2013 | US20130053378 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053366 Compounds and methods for treatment of hypertension |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053352 Diazeniumdiolate cyclopentyl derivatives |
| 02/28/2013 | US20130053351 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053336 Treatment of chlamydiaceae infections by means of beta-lactams |
| 02/28/2013 | US20130053335 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine |
| 02/28/2013 | US20130053332 Use |
| 02/28/2013 | US20130053321 Inhibitors of mitochondrial fission and methods of use thereof |
| 02/28/2013 | US20130053319 Chemokine derived peptides and uses for chronic wound and angiogenesis inhibition treatments |
| 02/28/2013 | US20130053317 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |